Recombinant adeno-associated virus expressing BDNF-HA2TAT, and construction method thereof
A construction method and virus technology, applied in the field of recombinant adeno-associated virus and its construction, can solve unreported problems and achieve the effect of preventing and treating depression and stress disorders
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Example 1 Construction of recombinant adeno-associated virus for packaging and expressing BDNF
[0035] Clone the BDNF cDNA fusion gene, connect the PCR product into the pGEM-T Easy vector, and obtain the pGEM-T Easy / BDNF transformed recipient strain E. Coli DH5α, the recombinant plasmid DNA was extracted by alkaline lysis, identified by enzyme digestion; the BDNF gene with cohesive ends was obtained by enzyme digestion, and the BDNF gene was inserted into the vector plasmid carrying the penetrating peptide TAT to construct the recombinant vector plasmid pSSCMV-BDNF-HA 2 TAT, recombinant plasmid pSSCMV-BDNF-HA 2 TAT was digested with EcoRI and BamHI to prepare BDNF-HA 2 The TAT fragment was connected to the PUC19 plasmid for sequencing; under the action of calcium phosphate, the recombinant vector plasmid pSSCMV-BDNF-HA 2 HEK293 cells were co-transfected with TAT, packaging plasmid pAAV / Ad and helper plasmid pFG140 to prepare and express BDNF-HA 2 Recombinant adeno...
Embodiment 2
[0277] Example 2 Expression of BDNF-HA 2 Animal experiment of recombinant adeno-associated virus of TAT
[0278] Recombinant adeno-associated virus expressing brain-derived neurotrophic factor enters the brain through the nasal-brain pathway to produce antidepressant-like effects: C57 BL / 6 female and male adult mice were divided into nasal instillation of normal saline and BDNF-HA 2 TAT / AAV two treatment groups, the two treatments were divided into 1d administration group, 5 consecutive days administration group and 10 consecutive days administration group; the 1d administration group underwent behavioral study on 1, 2, and 3 days after administration respectively. Test (forced swimming test (forced swimming test, FST) and open field exploration test (open-field exploration test, OPF), 5 consecutive days of administration group and 10 consecutive days of administration group respectively at 1, 3, 7 days after administration Behavioral tests (FST and OPF) were performed ...
PUM
Property | Measurement | Unit |
---|---|---|
Titer | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com